Showing results (21-30 of 1,229) with videos related to

Sort By:
Pageof 123
Jac-Antimicrobial Resistance|May 21, 2025
Current status and future direction of antimicrobial stewardship programs and antibiotic prescribing in primary care hospitals in ZambiaFaustina Makiko, Aubrey Chichonyi Kalungia, Martin Kampamba, et al.
Jac-Antimicrobial Resistance|May 20, 2025
Drug-resistant tuberculosis treatment success predictors in NamibiaVulika Nangombe, Mondjila Amkongo, Brian Godman, et al.
Jac-Antimicrobial Resistance|May 21, 2025
The price of WAR: AMRLaura J Rojas, Tracy L Lemonovich, Steven H Marshall, et al.
Jac-Antimicrobial Resistance|June 10, 2025
Genomic diversity of clinically relevant bacterial pathogens from an acute care hospital in Suva, FijiJane Hawkey, Michael J Loftus, Amitesh Prasad, et al.
Jac-Antimicrobial Resistance|June 9, 2025
Antibiotic use without prescription among children aged under 5 years in low- and middle-income countries: a systematic review and meta-analysisSegenet Zewdie, Assefa Andargie Kassa, Mekonen Melkie Bizuneh, et al.
Jac-Antimicrobial Resistance|June 12, 2025
Magnitude of vancomycin-resistant Enterococci colonization and associated factors among people living with HIVAbebe Dawud, Tadesse Shume, Rajesh Sarkar, et al.
Jac-Antimicrobial Resistance|May 9, 2025
Genomic characterization of multidrug-resistant tuberculosis in Shanghai, China: antibiotic resistance, virulence and transmissionYang Guo, Jing Lu, Peipei Jin, et al.
Jac-Antimicrobial Resistance|May 8, 2025
Tracking Antimicrobial Resistant Organisms Timely: a workflow validation study for successive core-genome SNP-based nosocomial transmission analysisKotaro Aoki, Kohji Komori, Tetsuo Yamaguchi, et al.
Jac-Antimicrobial Resistance|May 7, 2025
Feasibility of 24 h continuous-infusion cefiderocol administered by elastomeric pump in attaining an aggressive PK/PD target in the treatment of NDM-producing Klebsiella pneumoniae otomastoiditisStella Babich, Pier Giorgio Cojutti, Milo Gatti, et al.
Jac-Antimicrobial Resistance|August 20, 2025
First-in-human study of the benzothiazinone and DprE1 inhibitor BTZ-043, a novel drug candidate for the treatment of TuberculosisWandini Lutchmun, Norbert Heinrich, Elin M Svensson, et al.
Pageof 123